LATe Cerclage in High-risk Pregnancies (LATCH)
Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled Trial
Thomas Jefferson University
329 participants
Nov 10, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Transvaginal cervical cerclage placed between 24 0/7 - 26 6/7 weeks of gestation.
Continuing or initiation of vaginal progesterone 200mg daily until 36 weeks of gestation.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06036446